183 related articles for article (PubMed ID: 35821519)
1. A unique Smith-Magenis patient with a de novo intragenic deletion on the maternally inherited overexpressed RAI1 allele.
Sironi A; Bestetti I; Masciadri M; Tumiatti F; Crippa M; Pantaleoni C; Russo S; D'Arrigo S; Milani D; Larizza L; Finelli P
Eur J Hum Genet; 2022 Nov; 30(11):1233-1238. PubMed ID: 35821519
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal deletion and duplication of 17p11.2-11.2: Korean patients with Smith-Magenis syndrome and Potocki-Lupski syndrome.
Lee CG; Park SJ; Yun JN; Yim SY; Sohn YB
J Korean Med Sci; 2012 Dec; 27(12):1586-90. PubMed ID: 23255863
[TBL] [Abstract][Full Text] [Related]
3. Delayed diagnosis in a house of correction: Smith-Magenis syndrome due to a de novo nonsense RAI1 variant.
Yeetong P; Vilboux T; Ciccone C; Boulier K; Schnur RE; Gahl WA; Huizing M; Laje G; Smith AC
Am J Med Genet A; 2016 Sep; 170(9):2383-8. PubMed ID: 27311559
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion.
Vilboux T; Ciccone C; Blancato JK; Cox GF; Deshpande C; Introne WJ; Gahl WA; Smith AC; Huizing M
PLoS One; 2011; 6(8):e22861. PubMed ID: 21857958
[TBL] [Abstract][Full Text] [Related]
5. Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1.
Lacaria M; Gu W; Lupski JR
Am J Med Genet A; 2013 Jul; 161A(7):1561-8. PubMed ID: 23703963
[TBL] [Abstract][Full Text] [Related]
6. Detection of classical 17p11.2 deletions, an atypical deletion and RAI1 alterations in patients with features suggestive of Smith-Magenis syndrome.
Vieira GH; Rodriguez JD; Carmona-Mora P; Cao L; Gamba BF; Carvalho DR; de Rezende Duarte A; Santos SR; de Souza DH; DuPont BR; Walz K; Moretti-Ferreira D; Srivastava AK
Eur J Hum Genet; 2012 Feb; 20(2):148-54. PubMed ID: 21897445
[TBL] [Abstract][Full Text] [Related]
7. Smith Magenis syndrome: First case of congenital heart defect in a patient with Rai1 mutation.
Onesimo R; Delogu AB; Blandino R; Leoni C; Rosati J; Zollino M; Zampino G
Am J Med Genet A; 2022 Jul; 188(7):2184-2186. PubMed ID: 35373511
[TBL] [Abstract][Full Text] [Related]
8. Evidence for genetic regulation of mRNA expression of the dosage-sensitive gene retinoic acid induced-1 (RAI1) in human brain.
Chen L; Tao Y; Song F; Yuan X; Wang J; Saffen D
Sci Rep; 2016 Jan; 6():19010. PubMed ID: 26743651
[TBL] [Abstract][Full Text] [Related]
9. A de novo mutation (p.S1419F) of Retinoic acid induced 1 is responsible for a patient with Smith-Magenis syndrome exhibiting schizophrenia.
Yu R; Liu L; Chen C; Lin ZJ; Xu JM; Fan LL
Gene; 2023 Jan; 851():147028. PubMed ID: 36334618
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum.
Girirajan S; Vlangos CN; Szomju BB; Edelman E; Trevors CD; Dupuis L; Nezarati M; Bunyan DJ; Elsea SH
Genet Med; 2006 Jul; 8(7):417-27. PubMed ID: 16845274
[TBL] [Abstract][Full Text] [Related]
11. Copy number loss upstream of RAI1 uncovers gene expression regulatory region that may impact Potocki-Lupski syndrome diagnosis.
Alaimo JT; Mullegama SV; Thomas MA; Elsea SH
Mol Cytogenet; 2015; 8():75. PubMed ID: 26442755
[TBL] [Abstract][Full Text] [Related]
12. Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.
Rinaldi B; Villa R; Sironi A; Garavelli L; Finelli P; Bedeschi MF
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205380
[TBL] [Abstract][Full Text] [Related]
13. Inherited dup(17)(p11.2p11.2): expanding the phenotype of the Potocki-Lupski syndrome.
Magoulas PL; Liu P; Gelowani V; Soler-Alfonso C; Kivuva EC; Lupski JR; Potocki L
Am J Med Genet A; 2014 Feb; 164A(2):500-4. PubMed ID: 24311450
[TBL] [Abstract][Full Text] [Related]
14. Frameshift mutation hotspot identified in Smith-Magenis syndrome: case report and review of literature.
Truong HT; Dudding T; Blanchard CL; Elsea SH
BMC Med Genet; 2010 Oct; 11():142. PubMed ID: 20932317
[TBL] [Abstract][Full Text] [Related]
15. RAI1 point mutations, CAG repeat variation, and SNP analysis in non-deletion Smith-Magenis syndrome.
Bi W; Saifi GM; Girirajan S; Shi X; Szomju B; Firth H; Magenis RE; Potocki L; Elsea SH; Lupski JR
Am J Med Genet A; 2006 Nov; 140(22):2454-63. PubMed ID: 17041942
[TBL] [Abstract][Full Text] [Related]
16. Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes.
Bi W; Yan J; Shi X; Yuva-Paylor LA; Antalffy BA; Goldman A; Yoo JW; Noebels JL; Armstrong DL; Paylor R; Lupski JR
Hum Mol Genet; 2007 Aug; 16(15):1802-13. PubMed ID: 17517686
[TBL] [Abstract][Full Text] [Related]
17. Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic
Linders CC; van Eeghen AM; Zinkstok JR; van den Boogaard MJ; Boot E
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628566
[TBL] [Abstract][Full Text] [Related]
18. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
19. Nonrecurrent PMP22-RAI1 contiguous gene deletions arise from replication-based mechanisms and result in Smith-Magenis syndrome with evident peripheral neuropathy.
Yuan B; Neira J; Gu S; Harel T; Liu P; Briceño I; Elsea SH; Gómez A; Potocki L; Lupski JR
Hum Genet; 2016 Oct; 135(10):1161-74. PubMed ID: 27386852
[TBL] [Abstract][Full Text] [Related]
20. Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS.
Zhang F; Potocki L; Sampson JB; Liu P; Sanchez-Valle A; Robbins-Furman P; Navarro AD; Wheeler PG; Spence JE; Brasington CK; Withers MA; Lupski JR
Am J Hum Genet; 2010 Mar; 86(3):462-70. PubMed ID: 20188345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
